Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of…
LNCB74 is a B7-H4-targeting antibody-drug conjugate being developed for multiple cancers in partnership with LigaChem BiosciencesBELTSVILLE, Md., Dec. 10, 2024…
Award is being presented during Advanced Therapies Week 2025 in DallasMarlborough, Massachusetts--(Newsfile Corp. - December 10, 2024) - Phio Pharmaceuticals…
VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / Jolt Health Inc. (CSE:JOLT) ("Jolt" or the "Company") announces that in…
ARLINGTON, VA / ACCESSWIRE / December 9, 2024 / As the Senate moves this week to advance passage of the…
MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #boardofdirectors--Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of…
54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and…
Smarthood™ is the first solution to integrate IV workflow software, hardware, and peripherals directly into the hood enhancing best practices,…
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- StickIt Technologies Inc. (the" Company "or "StickIt") (CSE: STKT), an Israeli Canadian technology…
Dr. Jenny Fox From Children's Hospital of Richmond at Virginia Commonwealth University to Present Published Data and Firsthand Insights on…